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Abstract
Suppressive subtractive hybridization with polymerase chain reaction was used to identify the gene(s) associated with the CD8 cell
noncytotoxic anti-HIV response. The differences in gene expression profiles of CD8 cells from a pair of discordant HIV-positive identical
twins were studied. Forty-nine genes were identified as expressed at higher levels in the CD8 cells from the infected twin that inhibited
viral replication. The differential expression of these genes was then evaluated using Q-PCR to determine if this gene expression pattern
is evident in CD8 cells from other HIV-positive subjects showing this antiviral activity. Three genes, including one unknown, were found
to have significantly increased expression in antiviral CD8 cells.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
CD8 cells from healthy HIV-infected individuals can
inhibit virus production by infected CD4 cells without
killing the infected cell (Levy et al., 1996; Walker et al.,
1986; Wiviott et al., 1990). This CD8 cell noncytotoxic
antiviral response (CNAR), measured by cocultivating
CD8 cells with infected CD4 cells, involves suppression
of viral replication in a non-HLA restricted fashion at the
level of virus transcription (Chen et al., 1993; Copeland et
al., 1995; Levy et al., 1996; Mackewicz et al., 1995, 1998).
CNAR inhibits replication of all HIV-1 and HIV-2 strains
evaluated (Levy et al., 1996). A similar type of noncytotoxic
CD8 cell antiviral activity has been demonstrated in HIV-
infected chimpanzees (Castro et al., 1992), simian immu-
nodeficiency virus (SIV) infected rhesus monkeys (Ennen et
al., 1994; Kannagi et al., 1988; Powell et al., 1990), HIV-
2-infected baboons (Blackbourn et al., 1997), and FIV-
infected cats (Choi et al., 2000). The clinical relevance of
this CD8 cell antiviral response has been well documented
(Castelli et al., 2002; Gomez et al., 1994; Landay et al.,
1993; Levy et al., 1996; Mackewicz et al., 1991). In both
humans and rhesus monkeys this type of activity develops
early after infection and, in humans, it has been shown to
diminish over time concomitant with the development of
disease (Castelli et al., 2002; Gomez et al., 1994; Landay et
al., 1993; Mackewicz et al., 1991).
The mechanism of CNAR has been linked to the secre-
tion of a soluble CD8 cell antiviral factor, CAF, which is
produced in highest amounts by CD8 cells from HIV-
infected healthy individuals (Brinchmann et al., 1990; Levy
et al., 1996; Walker and Levy, 1989). Studies involving the
use of purified cytokines and their respective neutralizing
antibodies have distinguished CAF from other known cy-
tokines, including the interferons and various chemokines
with antiviral activity (Chun et al., 2001; Greco et al., 1999;
Lacey et al., 1997; Levy et al., 1996; Mackewicz et al.,
1994, 1996). Thus, CAF appears to be a novel antiviral
lymphokine.
One strategy directed at identifying of CAF is to isolate
the gene(s) responsible for this activity by examining the
differences in gene expression between CD8 cells that
produce this antiviral protein in culture and those that do
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not. A major problem involved in this approach is that CAF
is produced in very small amounts (e.g., 4 U/ml in which 1
U is 50% inhibition of HIV replication) (Levy et al., 1996),
making a distinction between CAF-producing cells and non-
producing cells difficult. Therefore, we have used CNAR
assays in which virus suppression of 90% can be achieved
with a low CD8 cell/infected CD4 cell input ratio.
The mRNA from CD8 cells obtained from a pair of
discordant HIV-infected identical twins were evaluated by
suppressive subtractive hybridization linked to polymerase
chain reaction (SSH-PCR). The CD8 cell population from
SV-2, the infected twin, inhibits viral replication in infected
CD4 cells, whereas the CD8 cells from SC, the unin-
fected twin, lack this activity. Once the differentially ex-
pressed genes in SV-2 were identified, quantitative-PCR
(Q-PCR) procedures were used to determine if the gene
expression pattern defined in SV-2 was present in other
individuals whose CD8 cells show this anti-HIV activity.
We now report the genes identified at higher levels in the
CD8 cells from HIV-positive individuals with CNAR.
Results
Isolation of CD8 cell mRNA
To isolate mRNA from CD8 cells showing CNAR
parallel acute infection assays were performed with cells
from SV-2 and SC. CD4 cells from the uninfected twin
(SC) were infected with HIV-1SF33 and split into three
cultures. In one culture, the acutely infected CD4 were
cocultured at a 1:1 ratio with CD8 cells from SC; in
another, they were cultured with CD8 cells from SV-2.
Control cultures contained the infected cells cultured alone.
After 5 days in coculture, the CD8 cells were removed
using immunomagnetic (IM) beads (Mackewicz et al.,
1994). In this coculture experiment, greater than 90% sup-
pression of virus replication was seen in the CD4 cells that
had been mixed with the infected twin’s (SV-2’s) CD8
cells, when compared to the CD4 alone control. No sub-
stantial suppression of virus replication was observed in the
cultures containing the uninfected twin’s (SC) CD8 cells
(Fig. 1).
Generation of subtracted libraries
The basic approach behind SSH-PCR is shown in Fig. 2.
The mRNA populations from the two types of cells to be
studied were converted into cDNA. In this approach, the
cDNA from the cells expressing the gene of interest or the
differential transcript is known as the “tester,” whereas the
reference cDNA, from cells that do not express the gene of
interest, is known as the “driver.”
In our study, three subtracted libraries consisting of dif-
ferent tester (SV-2 mRNA) to driver (SC mRNA) ratios
were generated as described under Materials and methods.
These different ratios helped to broaden the range of detec-
tion of mRNAs, especially those for which differential ex-
pression was 10-fold or less. The efficiency of the subtrac-
tion procedure was evaluated by using PCR amplification to
compare the abundance of Glucose-3-phosphate dehydro-
genase (G3PDH) mRNA in the subtracted and unsubtracted
samples. Results from the evaluation of the 1:30 subtraction
are shown in Fig. 3. In the subtracted sample, the G3PDH-
amplified band appeared at later cycles than in the unsub-
tracted sample. These results demonstrate a reduction in an
mRNA that is common to both cell populations.
Differential screening of subtracted libraries
Even though the subtracted libraries generated by SSH-
PCR are substantially enriched for differentially expressed
mRNAs, they still contain some sequences, especially
highly abundant ones, that are common to both cDNA
populations. This finding is supported by the observation
that given enough PCR cycles, G3PDH, a common tran-
script, was amplified from the subtracted samples (Fig. 3).
Common mRNAs in the subtracted library may be detected
when there are few differentially expressed mRNAs and
small differences in expression levels between the two cell
Fig. 1. Suppression of viral replication by CD8 cells from the HIV-
infected twin. CD8 cells from SV-2 (HIV-infected twin) and SC (unin-
fected twin) were cocultured with acutely infected CD4 cells. The amount
of viral replication is indicated by the level of reverse transcriptase (RT)
activity (Hoffman et al., 1985) in the coculture supernatant. The CD4 cell
control sample consisted of infected CD4 cells grown in the absence of
CD8 cells. Note that RT activity in the fluids from the SV-2 coculture of
CD8 cells from SV-2 with the acutely infected CD4 cells was unde-
tectable. The data shown are representative of six separate experiments.
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populations. Given that our experimental samples are both
from a specialized subset of T cells cultured under identical
conditions, the differences between them could be very
subtle. Therefore, we screened the subtracted library cDNA
fragments in a manner that would be stringent enough to
avoid isolating common mRNAs, but at the same time,
sensitive enough to identify mRNAs with low abundance
and/or low differential expression.
The individual clones from the subtracted library were
amplified by PCR in 96-well plates and the products were
spotted onto identical nitrocellulose membranes. Four mem-
branes were probed with 32P-labeled forward- and reverse-
subtracted probes as well as the unsubtracted cDNAs from
both the tester and the driver (see Materials and methods for
details). The reverse subtraction was made by performing
subtractive hybridization using the tester in the forward
subtraction as the driver and the driver from the former
experiment as the tester. Thus, in the reverse subtraction
procedure, SC CD8 cDNA was the tester and SV-2 CD8
cDNA was the driver. The probes derived from the reverse
subtraction as well as the driver cDNA (SC) served to decrease
the number of common mRNAs isolated from the procedure
since mRNAs differentially expressed by SV-2 should not be
present in either of those samples. Furthermore, using the
forward subtracted library as one of the probes increased the
sensitivity of the screening procedure by identifying relatively
faint signals corresponding to rare transcripts.
Since we screened more than one 96-well plate, each set
of nitrocellulose membranes was also probed with a mixture
of 32P-labeled cDNAs corresponding to differentially ex-
pressed mRNAs identified in previous rounds of screening.
This latter part of the procedure was designed to minimize
the isolation of repeated mRNAs. A representative set of
membranes used in this procedure is shown in Fig. 4. The
arrows indicate genes that were selected as being expressed
only in SV-2 because their signal was stronger in the mem-
branes hybridized to the forward-subtracted and unsub-
tracted probes. Moreover, little or no signal was observed
when the membranes were probed with other clones already
selected in previous rounds of differential expression (shown
by the membrane labeled “Mixed clone probe,” Fig. 4).
Differentially expressed genes
A total of 1056 clones from the three subtractions were
screened and 49 differentially expressed cDNAs were iden-
tified and are summarized in Table 1. From the 1:30 sub-
tracted library, 576 clones were screened and 47 were found
differentially expressed by the criteria described above and
under Materials and methods. One hundred ninety-two
clones were screened from the subtraction performed at a
1:40 ratio and eight were found to be differentially ex-
pressed. However, when these clones were compared
against those identified from the 1:30 subtracted library,
they were all found to be redundant. This result indicated
that a 1:30 ratio was sufficient to identify differentially
expressed genes that are either abundantly expressed or
expressed at a greater than 10-fold difference when com-
pared to genes expressed in the CD8 cells that did not
show CNAR. We screened 96 clones from the subtraction
performed at the 1:25 ratio and found 16 differentially
expressed sequences, of which 2 were found to be nonre-
dundant. Presumably, these clones represent cDNAs that
were excluded from the 1:30 subtraction because they are
either expressed at a low copy number or have a low level
(less than 10-fold) differential expression.
Fig. 2. The subtractive hybridization procedure used to generate a forward-
subtracted library containing transcripts differentially expressed in the
CD8 cells from the HIV-infected twin. Total RNA was isolated from
CD8 cells purified from the coculture assay as described. Complementary
DNA synthesis was carried out using the PCR-based SMART Kit. The
cDNA was digested with RsaI and the tester cDNA was ligated with two
different adaptors as described under Materials and methods. Two rounds
of hybridization using an excess driver were conducted and the differen-
tially expressed cDNAs were amplified through two rounds of PCR (see
Materials and methods for more details).
Fig. 3. Evaluation of the efficiency of the SSH-PCR forward subtraction.
Amplification of G3PDH transcripts in both the forward-subtracted sec-
ondary PCR products and the unsubtracted samples. The figures corre-
spond to the number of PCR cycles. A decrease in the amount of G3PDH
cDNA in the subtracted library can be observed.
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BLAST homology searches of the sequences corre-
sponding to the 49 clones identified revealed 39 unique
transcripts. The majority of them were homologous to genes
of known function (Table 1). The differential expression of
genes involved in cell maintenance and division such as
CDC28 protein kinase I, ribosomal protein L3, and the
cell-cycle regulatory protein (p95) may reflect a higher level
of activation in CD8 cells from HIV-infected individuals
and therefore, the need for increased protein synthesis and
cellular turnover. Two genes directly involved in apoptosis
were also identified. Since CNAR does not involve cell
killing (Levy et al., 1996; Wiviott et al., 1990), these genes
would not be directly related to this antiviral process.
Five genes have been previously reported to be ex-
pressed by T-lymphocytes. -2-Microglobulin is a compo-
nent of major histocompatability complex class I molecules,
Fig. 4. Differential screening of subtracted library. The results shown are of differential screening of one of the 11 sets of 96 clones tested. The subtracted
library was cloned and amplified as described under Materials and methods. Five identical membranes were spotted and each was hybridized to the probe
indicated. Four of the probes consisted of either a subtracted or unsubtracted library of cDNAs, while the fifth probe was made up of a mixture of clones
already identified as differentially expressed. The positive clones from this screening are indicated by arrows and were selected as described under Materials
and methods.
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which has been previously reported to be expressed on the
surface of T cells isolated from HIV-positive individuals
(Prince et al., 1990). Lymphoid phosphatase and SHP-2
interacting transmembrane adaptor protein are both recently
identified proteins believed to be directly involved in T cell
activation (Cohen et al., 1999; Marie-Cardine et al., 1999).
Natural killer cell transcript 4 and NKG7 are transcripts
associated with natural killer cells but have also been de-
tected in activated CD8 T cells (Dahl et al., 1992; Turman
et al., 1993). Three transcripts identified (Table 1), that have
been characterized in tissues not involved in the immune
system, have no known function in CD8 cells. Finally, 13
transcripts were identified in the subtracted library that are
classified as “unknown” since there is no phenotype asso-
ciated with their protein product.
Quantitative PCR analysis of differentially expressed
clones
To confirm the differential expression of the selected
genes in a number of HIV-positive individuals with CNAR,
we measured the RNA expression levels of seven known
Table 1
Genes differentially expressed by CD8 cells from the HIV-positive twin (SV-2)
Function Gene name Accession No.
Immune response Natural killer cell transcript 4 NM_004221
-2-microglobulin NM_004048
NKG7 cell-surface protein NM_005601
Lymphoid phosphatase NM_012411
SHP2 interacting transmembrane adaptor NM_014450
Heat shock protein 90 NM_005348
Guanylate binding protein 4 AF288814
Apoptosis Inhibitor of apoptosis 1 NM_001165
CASP8 associated protein NM_012115
Cell maintenance Cell-cycle regulatory protein (p95) NM_002485
Isocitrate dehydrogenase 3 NM_004135
CDC28 protein kinase I NM_001826
Protein kinase C theta NM_006257
Enhancer of filamentation NM_006403
BAP29/BAP31 NM_005745
Kinase anchor protein 13 NM_006738
High mobility group proteina NM_005517
Myosin regulatory light chain NM_006471
Mitochondrial ATPase coupling factor NM_001685
Ribosomal protein L3 NM_000967
Translation elongation factorb NM_001402
Human mitochondria complete genomec AF347015
Tyrosene 3 monooxygenase activation protein BC003623
Stress-associated endoplastic reticulum protein 1 NM_014445
Miscellaneous Immature colon carcinoma transcript I NM_001545
Unknown Hypothetical protein FLJ13949d NM_025077
Hypothetical protein c3orf4 NM_019895
EST IMAGE:292217 N62461
EST IMAGE:2354339 AI719173
PTD010 Protein NM_014394
cDNA clone IMAGE:3890641 BE876822
Hs chromosome 17 clone hRPK.136_H_19 AC005856
Hypothetical protein FLJ13046 AB051508
cDNA clone KAIA1180 AK026418
EST IMAGE: 701434 AA286854
Human mRNA for KIAA0212 gene NM_014674
CDA02 protein NM_032025
cDNA clone IMAGE:911754 AA483944
cDNA clone AW975741
Human sequencee
Human sequence
Human sequence
a Two clones showed homology to High mobility group protein (NM_005517).
b Four clones showed homology to Translation elongation factor (NM_001402).
c Three clones showed homology to Human mitochondria complete genome (AF347015).
d Two clones showed homology to Hypothetical protein FLJ3943.
e Clones denoted as “Human sequence” shared no significant homology to any sequence in the NCBI Database.
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and nine unknown sequences identified. The known tran-
scripts chosen for this analysis were those which had a
specific role in T cell function. Furthermore, because of the
novel nature of CAF, we analyzed the expression patterns of
transcripts with no known phenotypes. The RNA samples
used in these studies were isolated from CD8 cells with
antiviral activity (90%) from six different subjects. These
samples were compared to RNA from CD8 cells obtained
from six uninfected individuals showing no antiviral activ-
ity (20%). The CD8 cells from both the infected and the
uninfected individuals were subjected to the coculture assay
to confirm the presence or absence of viral suppression.
G3PDH was used to normalize each sample and the relative
abundance of each mRNA was calculated using the com-
parative Ct method (Livak and Schmittgen, 2001). The level
of G3PDH transcript varied by less than 5% from sample to
sample, making it a suitable transcript for normalization.
The results of these analyses are summarized in Fig. 5.
Three transcripts, NKG7, immature colon carcinoma 1
(ICT1), and hypothetical protein FLJ3949, were found to be
significantly overexpressed (P  0.1) (Table 3) in the HIV-
positive individuals when compared to the uninfected sub-
jects.
Discussion
CD8 cells from healthy HIV-infected individuals have
been shown to inhibit viral replication through a noncyto-
toxic mechanism (Levy et al., 1996; Walker et al., 1986). To
identify the gene or genes responsible for this activity, we
employed SSH-PCR to study, in HIV-discordant identical
twins, the differentially expressed messenger RNA (mRNA)
in the CD8 cells showing CNAR compared to the CD8
cells that do not (Figs. 2 and 3). SSH-PCR is a modification
of representational differential analysis (RDA), which was
developed to identify chromosomal aberrations and restric-
tion fragment length polymorphisms between two complex
genomes (Lisitsyn, 1995). RDA protocols have been sub-
sequently adapted to study differences in mRNA expression
between two cell populations. These modifications account
for differences in mRNA abundances during the hybridiza-
tion step as well as incorporate suppression PCR to enrich
for rare mRNAs (Diatchenko et al., 1996). Other groups
have reported that SSH-PCH can isolate differentially ex-
pressed transcripts that are found in low amounts (von Stein
et al., 1997; Wan et al., 1996).
Using CD8 cell samples from a pair of HIV-discordant
identical twins gives an advantage over unrelated individu-
als because their similar genetic background allows for the
identification of differentially expressed genes that are more
likely based on the process being studied and not on other
genetic distinctions (MacGregor et al., 2000). In our study,
CD8 cells from the HIV-infected twin showed antiviral
activity, whereas the uninfected twin did not (Fig. 1). Using
the CD8 cells that exhibited the antiviral activity, we
identified 49 genes that were expressed at higher levels
(Table 1).
The genes of known function identified in the subtracted
library covered a wide range of cellular processes. The
majority of these were involved in energy generation, cell-
cycle regulation, cell maintenance, and apoptosis. The up-
regulation of these genes in CD8 cells from HIV-positive
individuals may indicate an activated immune system due to
Fig. 5. The mRNA expression levels of 16 genes identified by suppressive subtractive hybridization. Mean mRNA expression in CD8 cells from six
HIV-positive individuals with CNAR (black bars) and six HIV-negative subjects (white bars) standardized by the level of G3PDH and reported in arbitrary
units. CD8 cells were cultured, isolated, and assayed for antiviral activity as described under Materials and methods. Gene-specific primer pairs were
subjected to PCR once. Each RNA sample was run in triplicate. Numbers correspond to the following genes: 1, NKG7; 2, immature colon carcinoma
transcript 1; 3, hypothetical protein FLJ13949; 4, SHP2 interacting protein; 5, hypothetical protein C3orf4; 6, Lyp phosphatase; 7, hypothetical protein
FLJ13046; 8, cDNA clone KAIA1180; 9, guanylate binding protein 4; 10, heat shock protein 90; 11, natural killer cell transcript 4; 12, PTD010 protein; 13,
CDA02 protein; 14, EST387850; 15, -2-microglobulin; 16, KIAA0212. P values were calculated using the exact Wilcoxon rank-sum test. NS, not
significant.
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a chronic infection requiring faster cell turnover and are
likely not directly involved in the generation of CNAR.
Seven of the transcripts identified are specifically associated
with the immune response. They are involved in the acti-
vation of the T cell receptor, natural killer (NK) and cyto-
toxic cell activity, and the interferon pathway. The presence
of these genes in the subtracted library may be a reflection
of the multiple functions of CD8 cells during HIV infec-
tion.
To further validate the differential expression of the
genes with potential involvement in CNAR, we used Q-
PCR to measure the levels of expression of these genes in
other HIV-positive individuals whose CD8 cells show
anti-HIV activity. We selected seven transcripts involved in
immune responses as well as nine transcripts that had no
known phenotype (Table 2). Genes that encoded proteins
involved in general cell maintenance were not included in
the analysis. Even though the majority of the genes tested
demonstrated a trend of higher expression in the infected
individuals, only three were found to be significantly up-
regulated in the HIV-positive subjects (P  0.1) (Fig. 5 and
Table 3). NKG7 is a transmembrane protein associated with
granules on NK cells and cytotoxic T cells, which translo-
cates to the plasma membrane upon antigen recognition
(Medley et al., 1996). Since the mRNA used in these studies
was derived from a heterologous population of CD8/
CD3 cells, it is expected that cytotoxic T cells were
present. The possible role of NKG7 in the nonkilling effect
of CNAR is being investigated. ICT1 is a transcript origi-
nally found as a differentiation marker in a colon carcinoma
cell line (HT29-D4) (van Belzen et al., 1995). The ICT1
gene and the resulting protein was found to be expressed at
higher levels in undifferentiated HT29-D4 cells when com-
pared to differentiated cells; however, the exact function of
this protein has not been determined. The third transcript
identified corresponds to hypothetical protein FLJ13949.
Information from NCBI (www.ncbi.nlm.nih.gov) regarding
this transcript suggests that this gene is expressed in a wide
variety of tissues; however, the protein has yet to be de-
tected. Studies are now directed at defining a role this
protein could have in CNAR.
In summary, using the SSH-PCR approach, we report the
finding of several genes expressed at higher levels in CD8
cells exhibiting a noncytotoxic, anti-HIV response. Three
Table 3
Distribution of relative mRNA expression data from Q-PCR for differentially expressed genes
Gene Samplea Mean Median Standard
errorb
Range P valuec
ICT1 HIV 52.2 36.9 19.3 23.3–142.1 0.09
HIV 18.9 15.4 5.0 6.1–36.7
NKG7 HIV 450.7 222.3 179.5 30.7–1072.8 0.06
HIV 63.4 27.2 35.0 15–232.4
FLJ13949 HIV 568.0 555.7 189.6 55.5–1236.4 0.09
HIV 199.1 71.5 99.3 30.5–640.0
a N  6 for HIV and HIV subjects.
b Standard error of the mean  standard deviation/square root n.
c P value calculated using Wilcoxon rank sum test.
Table 2
Primers for Q-PCR analysis
Gene Forward Reverse
NKG7 5CTCGGGCCTCTGGCCAA 5GAGACCCAGCCCAGGTAGAA
Immature colon carcinoma transcript 1 5GCGCTGCACAAGCAGAAA 5CAGGACCACTACTCCGACAA
Hypothetical protein FLJ13949 5TCCCGTAGTGGATGTGCAAA 5AAGCCATGCTGTATCAGGAA
SHP2 interacting protein 5AAACCGTCAGGCCATGAA 5CCTGGTCCACTGGGACAA
Hypothetical protein C3orf4 5GGTGTATCACCATACCCAAAA 5CGGCAAATGCAAGCACAAA
Lyp phosphatase 5ACCAAGTACAAGGCAGACAAA 5AAGGACCCTGGGTGGCAA
FLJ13046 5AACAACGCCAGCATGCAGA 5TGAAGGTTGGGCCTTTGTAAG
cDNA clone KAIA1180 5CAGGCACACACCACCACG 5CGCCCATAATCCCAACAC
Guanylate binding protein 4 5GGCTATACCGCACAGGAAA 5AGGCCCTCGGTGTCCAGA
Heat shock protein 90 5AGCACAATGGCTGGACAGCAAA 5GATCTTCCGACTGAAGCCAGAA
Natural killer cell transcript 4 5GGTCCTCTCTGATGACATGAA 5TCTATGGCCTGGTGCTGTGAA
PTD010 protein 5AAGGAAACTGCGAGGCGAA 5GTGGAGAGGCCTCCCACAA
CDA02 protein 5AGATGGCACAGCTGGGATA 5AACATTGCGGGCACAAAGA
EST387850 5TTCCTAAATTCGCAAGATTTCA 5AGCTCCTTCCCCCTCAGAGT
B-2 microglobulin 5CCTGGAGAGTATGGAAAGGAA 5CAAGTCCTCTCTCGGGAGTGA
KIAA0212 5GACTCCTGGGGGACTCCAC 5CTTCCCGCCCTCTTCTTAA
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genes appear to be significantly increased in expression.
Further studies are needed to determine the levels of the
proteins encoded by these genes and their relevance in
CNAR.
Materials and methods
Subjects
Peripheral blood samples were obtained by venipuncture
in Vacutainer tubes containing sodium heparin from a pair
of discordant HIV-infected female identical twins (SV-2,
HIV-positive; SC, HIV-negative). SV-2 was clinically
healthy, was not on antiretroviral therapy, and had a CD4
T cell count of 400 cells per microliters.
Isolation of cell subsets
Peripheral blood mononuclear cells (PBMC) were ob-
tained by Ficoll–Hypaque (Sigma Chemical Co., St. Louis,
MO) gradient centrifugation (Mackewicz et al., 1991) and
stimulated with phytohemagglutinin (3 g/ml; Sigma) for 3
days in RPMI 1640 medium containing 10% heat-inacti-
vated (56°C, 30 min) fetal bovine serum (BioWhittaker,
Walkersville, MD) supplemented with 2 mM glutamine
(BioWhittaker), 100 g/ml streptomycin (BioWhittaker),
100 units/ml penicillin (BioWhittaker), and 100 U/ml of
recombinant IL-2 (rIL-2; generously provided by Glaxo-
Wellcome) (Mackewicz et al., 1998). CD8 and CD4 cells
from the activated PBMC were subsequently obtained by
positive selection using immunomagnetic (IM) beads bear-
ing anti-CD4 or anti-CD8 monoclonal antibodies (Dynal,
Lake Success, NY) (Mackewicz et al., 1995, 1998). The IM
beads were removed from the cells by Detach-a-Bead (Dy-
nal). Purity of the cell subset population was confirmed by
flow cytometry by which 95% of the cells were CD4 or
CD8 cells, respectively (Levy et al., 1985).
Acute infection assay
Acute virus suppression assays were carried out as pre-
viously described (Mackewicz et al., 1995, 1997, 1998,
1991). In brief, purified CD4 cells from SC were infected
with 10,000 TCID50 of the -chemokine-insensitive HIV-
1SF33 strain (Mackewicz et al., 1997) and cultured in growth
medium containing 100 U/ml of recombinant IL-2 (Collab-
orative Biomedical Products, Bedford, MA) both alone and
in the presence of CD8 cells at a 1:1 cell input ratio. After
5 days of coculture, fluids were collected from the culture
for reverse transcriptase (RT) assays (Hoffman et al., 1985;
Mackewicz et al., 1997) and the CD8 cells were isolated
with IM beads as described (Mackewicz et al., 1994). Acute
infection assays with CD8 cells from subjects without an
identical twin were performed as described above using
CD4 cells from anonymous blood donors.
RNA isolation and cDNA synthesis for SSH
Total RNA was extracted from the purified CD8 cells
recovered from the acute infection assays using the Trizol
reagent (Life Technologies Inc., Gaithersburg, MD) accord-
ing to the manufacturer’s protocols. Due to the limited
amount of total RNA isolated from the purified CD8 cells,
the cDNA used in the subtraction was prepared directly
from total RNA by the SMART PCR cDNA synthesis kit
(Clontech, Palo Alto, CA) following the manufacturer’s
instructions.
Suppressive subtractive hybridization, polymerase chain
reaction procedure, and differential screening
SSH-PCR was performed using the PCR Select cDNA
subtraction Kit (Clontech) according to the manufacturer’s
recommendations. The tester and driver cDNAs are di-
gested with RsaI and the tester was ligated to adaptors that
will provide a common binding site for PCR primers in later
steps of the procedure. The tester and driver then underwent
two rounds of hybridization using excess driver, and the
double-stranded hybrid sequences were removed. This pro-
cedure eliminates the mRNAs common to both cDNA pop-
ulations. The remaining cDNAs represent genes that are
expressed differentially in the tester cDNAs. Since the tester
cDNAs were ligated to adaptors specific for PCR primers, it
is possible to amplify the mRNAs represented in the sub-
tracted library. This approach can result in a substantial
enrichment of rare mRNAs (Diatchenko et al., 1996).
In the forward subtraction, the cDNA derived from SV-2
CD8 cells was used as the tester and the cDNA from SC
CD8 cells was used as the driver. In the reverse subtrac-
tion, SC cDNA served as the tester and SV-2 cDNA served
as the driver (see Fig. 2). The cDNAs were hybridized at
three different tester:driver ratios (1:25, 1:30, and 1:40). To
evaluate the efficiency of cDNA subtraction, we compared
the expression levels of G3PDH in subtracted and unsub-
tracted cDNA populations. The fragments from the for-
ward-subtracted reaction were then inserted into the vector
pTOPO (Invitrogen, Carlsbad, CA). Transformants contain-
ing individual cDNA fragments were identified using blue/
white screening on agar plates supplemented with 5-bromo-
4-chloro-3-indolyl--D-galactosidase (X-gal) (Life Tech-
nologies).
For differential screening of the forward-subtracted li-
brary a total of 864 (9 rounds of 96 clones: 576 from the
1:30 reaction, 192 from 1:40, and 96 from 1:25) individual
recombinant clones were picked and used to inoculate 96-
well microtiter plates containing 100 l of LB medium
(GIBCO-BRL, Gaithersburg, MD) at 37°C overnight. The
procedure was carried out using the PCR Select Differential
Screening Kit (Clontech). One microliter of the overnight
culture from each clone was transferred to a 96-well plate
containing the PCR reaction mix recommended by the man-
ufacturer to serve as a template for PCR. Each PCR reaction
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was evaluated by gel electrophoresis on a 1% agarose gel to
ensure that the clone fragment had been successfully am-
plified. Six microliters of the PCR reaction was then trans-
ferred to a nylon membrane. Five identical membranes of 96
clones each were prepared and then hybridized with 32P-
labeled forward reaction, reverse reaction, and SV-2 and SC
unsubtracted probes. One hundred nanograms of each probe
was labeled using the Random Primers DNA Labeling Sys-
tem (Life Technologies) and 50 uCi of [-32P]dCTP, (3000
Ci/mmol, 10 uCi/ul) (NEN Life Science Products, Boston,
MA). Unincorporated nucleotides were removed by size
exclusion chromatography columns (CHROMA SPIN-100,
Clontech). The specific activity of the probes was approxi-
mately 107 cpm/100 ng. An equal number of cpm for each
probe was added to the appropriate membrane. Hybridiza-
tion of the radioactively labeled probes to the membranes
was carried out as described in the PCR-Select Differential
Screening Kit Manual. Membranes were exposed to Kodak
Biomax MR Film overnight with an intensifying screen at
70°C.
Clones were regarded as differentially expressed if they
were hybridized to the forward-subtracted and unsubtracted
SV-2 probes only or hybridized to all the probes but the
signal intensity was higher on the forward-subtracted and
SV-2 probes. To avoid selecting the same clone more than
once, the fifth membrane was probed with a 32P-labeled mix
of clones found differentially expressed in previous rounds
of screening. The selected differentially expressed clones
were then sequenced and compared to known GenBank
sequences through a BLAST search (www.ncbi.nih.gov).
Quantitative PCR
RNA concentration was determined by spectrophotome-
ter and adjusted to a concentration of 200 ng/l. Five
hundred nanograms of total RNA was reverse transcribed
using 250 U of murine leukemia virus RT (Invitrogen) in
1 Amplitaq Buffer (Applied Biosystems, Foster City, CA)
supplemented with 7.5 mM MgCl2 with 5 M random
hexamers (Invitrogen), 1 mM each of dNTPs (Invitrogen),
and 40 U of RNase inhibitor (Promega, Madison, WI). The
reaction mixture was incubated at 25°C for 10 min, 48°C for
40 min, and 95°C for 5 min. Five microliters of a 1:10
dilution of the RT reaction was subjected to PCR using the
GeneAmp 5700 Sequence Detection System, SYBR Green
PCR Master Mix (Applied Biosystems), and 4 M primer
mix in a 25 L reaction. Cycling conditions were as fol-
lows: initial denaturation at 95°C for 10 min followed by 50
cycles at 95°C for 15 s, and 60°C for 1 min. Primer pairs for
each individual gene were designed using Oligo Primer
Analysis Software V.6 (Molecular Biology Insights, Cas-
cade, CO). The primer sequences were subjected to BLAST
analysis to confirm their specificity for a single gene. The
generation of a single PCR product by each primer pair was
tested using the Universal Human Reference RNA (Strat-
agene, La Jolla, CA). The reverse transcription and PCR
reactions were carried as described above. Primer sequences
for each transcript tested are shown in Table 2.
Statistical methods
Statistical analysis was done by the R software package
(http://lib.stat.cmu.edu/R/CRAN). The exact Wilcoxon
rank-sum test was used to evaluate the significance of
mRNA expression differences between the infected and
uninfected groups for each gene tested.
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